Authors:
Margenthaler, JA
Virgo, KS
Johnson, DY
Sugarbaker, EM
Handler, BS
Johnson, FE
Citation: Ja. Margenthaler et al., How surgeon age affects post-treatment surveillance strategies for melanoma patients, INT J ONCOL, 19(1), 2001, pp. 175-180
Authors:
Margenthaler, JA
Yu, S
Otomo, N
Shimizu, Y
Fiye, MW
Citation: Ja. Margenthaler et al., Portal venous tolerance in the anti-class I L-d alloantigen 2C transgenic mouse, TRANSPLAN P, 33(1-2), 2001, pp. 143-144
Authors:
Shimizu, Y
Otomo, N
Yu, S
Margenthaler, JA
Flye, MW
Citation: Y. Shimizu et al., Donor-specific antigen transfusion-mediated cardiac allograft tolerance isprevented by prior treatment with anti-CD8, but not anti-CD4, antibody, TRANSPLAN P, 33(1-2), 2001, pp. 150-151
Authors:
Otomo, N
Motoyama, K
Yu, S
Shimizu, Y
Margenthaler, JA
Tu, F
Flye, MW
Citation: N. Otomo et al., Intrathymic alloantigen-mediated tolerant, completely MHC-mismatched mousehearts are specifically rejected by adoptively transferred in vitro-sensitized anti-class I Ld+-specific 2C cells, TRANSPLAN P, 33(1-2), 2001, pp. 159-160
Authors:
Margenthaler, JA
Otomo, N
Shimizu, Y
Yu, S
Flye, MW
Citation: Ja. Margenthaler et al., Delayed type hypersensitivity in the CD8+dominant anti-class I L-d alloantigen 2C transgenic mouse is mediated by small but significant CD4 population, TRANSPLAN P, 33(1-2), 2001, pp. 338-339
Authors:
Otomo, N
Margenthaler, JA
Motoyama, K
Arima, T
Shimizu, Y
Lehmann, M
Flye, MW
Citation: N. Otomo et al., Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration, J SURG RES, 98(1), 2001, pp. 59-65